3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
5
Multiple Myeloma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Neoplasms
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Pharyngeal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Neurofibrosarcoma
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Neoplasms, Mesothelial
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Mouth Neoplasms
1
Melanoma
1
Interventions
X-Rays
6
Specimen Handling
6
Cyclophosphamide
6
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Nuclear Medicine Department, Hospital
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
mifamurtide
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Sirolimus
×
30 days
×
Clear all
No trials found.